Dr. Jerry Vockley provides updates on the latest in therapy development for the FAOD community at the 2022 International Metabolic Conference.
MELAS Spectrum Disorders and Sonlicromanol: Progress Update
Join MitoAction and Dr. Jan Smeitink, CEO of Khondrion for our our March Expert Series presentation. MELAS spectrum (m.3243A>G) disorders belong to the most frequently encountered group of primary mitochondrial […]
The Mito Cocktail Revisited
Join MitoAction and Acton Pharmacy’s Clinical Pharmacist, Ted Toufas as we revisit and provide the latest updates about the mito cocktail! The mito cocktail is one of the front-line treatment […]
PTC743 (Vatiquinone) for the Treatment of Mitochondrial Disease With Associated Epilepsy
Join MitoAction and Matthew Klein and Francesco Bibbiani from PTC Therapeutics for our November Mito Expert Series presentation titled, “PTC-743 (Vatiquinone) for the Treatment of Mitochondrial Disease With Associated Refractory Epilepsy”.
Ultragenyx Q&A – A Conversation with Ultragenyx’s CMO and Global Metabolic Dietitian
A Conversation with Ultragenyx’s Chief Medical Officer, Camille Bedrosian to discuss Insights into Future LC-FAOD Research. Also hear from Ultragenyx’s Global Metabolic Dietitian, Bridget Reineking on How to Use the […]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 7
- Next Page »
